The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection

Archives of Internal Medicine

Volumn 158, Issue 5, 1998, Pages 491-497

  Mocroft, Amanda ^a   Youle, Michael ^b   Phillips, Andrew N ^a   Halai, Ramesh ^b   Easterbrook, Phillipa ^c   Johnson, Margaret A ^a   Gazzard, Brian ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HIV Genitourinary Med Research Unit   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; SEX DIFFERENCE; UNITED KINGDOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONDON; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0032498691     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.5.491     Document Type: Article

References (41)

1. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr. 1991;4:770-776.
2. Hanson DL, Chu S, Farizio KM, Ward JW, and the Adult and Adolescent Spectrum of HIV Disease Project Group. Distribution of CD4+ lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. Arch Intern Med. 1995;155:1537-1542.
3. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996;124:633-642.
4. 3. J Infect Dis. 1994;170: 1284-1287.
5. Gable CB, Tierce JC, Simison D, Ward D, Motte K. Cost of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols. J Acquir Immune Defic Syndr. 1996;12:413-420.
6. SAS Institute Inc. SAS/STAT Users Guide, Version 6. 4th ed. Cary, NC: SAS Institute Inc; 1989:2.
7. Luo K, Law M, Kaldor JM, McDonald AM, Cooper DA. The role of initial AIDS-defining illness in survival following AIDS. AIDS. 1995;9:57-63.
8. Stoneburner R, Laroche E, Prevots R, et al. Survival in a cohort of human immunodeficiency virus infected tuberculosis patients in New York City: implications for the expansion of the AIDS case definition. Arch Intern Med. 1992;152: 2033-2037.
9. Korzeniewska-Kosela M, Fitzgerald JM, Vedal S, et al. Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases. Can Med Assoc J. 1992;146:1927-1934.
10. Fiala M, Kermani V, Gornbein J. Role of CD8+ in late opportunistic infections of patients with AIDS. Res Immunol. 1992;143:903-907.
11. Pertel P, Hirschtick R, Phair J, et al. Risk of developing cytomegalovirus retinitis in persons with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5:1069-1074.
12. Monforte AA, Mainini F, Vago L, et al. Factors associated with increased risk of acquiring cytomegalovirus disease in AIDS patients. J Infect Dis. 1993;168:1071-1072.
13. Horsburgh CR Jr, Havlik JA, Ellis DA, et al. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium-intracellulare complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis. 1991;144:557-559.
14. Baldassano V, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med. 1995;333:670.
15. Chin DP, Reingold AL, Stone EN, et al. The impact of Mycobacterium avium-intracellulare complex bacteremia and its treatment on survival of AIDS patients: a prospective study. J Infect Dis. 1994;170:578-584.
16. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223-1227.
17. Gallant JE, Moore RD, Richmann DD, Keruly J, Chaisson RE. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Arch Intern Med. 1994;154:566-572.
18. Lundgren JD, Melbye M, Pederson C, Rosenberg PS, Gerstoft J. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. Am J Epidemiol. 1995;141:652-658.
19. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 1995;333:845-851.
20. Veenstra J, Krol A, van Praag RME, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS. 1995;9:1153-1158.
21. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with the human immunodeficiency virus: a summary. MMWR Morb Mortal Wkly Rep. 1995;44:1-35.
22. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis. 1993;168:61-67.
23. Carpenter CCJ, Mayer KH, Stein MD, Leibman BD, Fisher A, Fiore TC. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine (Baltimore). 1991;70:307-325.
24. Carpenter CJ, Mayer KH, Fisher A, Desai MB, Durand L. Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am J Med. 1989; 86:771-775.
25. Greenberg AE, Thomas PA, Landesman SH, et al. The spectrum of HIV-1 related disease among outpatients in New York City. AIDS. 1992;6:849-859.
26. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990;335:123-128.
27. Peterman TA, Jaffe HW, Beral V. Epidemiological clues to the etiology of Kaposi's sarcoma. AIDS. 1993;7:605-611.
28. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma associated herpes virus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995;346:799-802.
29. Su IJ, Hsu YS, Chang YC, Wang IW. Herpes virus-like DNA sequences in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet. 1995;345: 722-723.
30. Chang Y, Cesarman E, Pessin MS, et al. Identification of new human herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266: 1865-1869.
31. Havlik JA, Horsburgh CR, Metchock B, Williams PP, Fann SA, Thompson SE. Disseminated Mycobacterium avium-intracellulare complex infection: clinical identification and epidemiological trends. J Infect Dis. 1992;165:577-580.
32. Montaner JSG, Le T, Hogg R, Ricketts M, Sutherland D, Strathdee SA. The changing spectrum of AIDS index diseases in Canada. AIDS. 1994;8:693-696.
33. Munoz A, Carey V, Saah AJ, et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1988;1:396-404.
34. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis carinii pneumonia. N Engl J Med. 1993;329:1922-1926.
35. Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicentre AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993;137:423-438.
36. Graham NM, Zeger SL, Park LP, et al. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. Lancet. 1991;338:265-269.
37. Boyer GS, Templin OW, Goring WP, et al. Discrepancies between patient recall and the medical record: potential impact on diagnosis and clinical assessment of chronic disease. Arch Intern Med. 1995;155:1868-1872.
38. Parent ME, Ghadirian P, Lacroix A, Perret C. Accuracy of reports of familial breast cancer in a case-control series. Epidemiology. 1995;6:184-186.
39. Githens PB, Glass CA, Sloan FA, Entmann SS. Maternity recall and medical records: an examination of events during pregnancy, childbirth and early infancy. Birth. 1993;20:136-141.
40. Mocroft A, Youle M, Morcinek J, et al. Has survival after AIDS improved? evidence from 2625 patients with AIDS. BMJ. 1997;314:409-413.
41. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV-infected patients in Switzerland: prospective multicenter study. BMJ. 1997;315:1194-1199.